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Objective: Although analgesic approaches targeting nerve growth factor (NGF) for the treatment of
osteoarthritis (OA) pain remain of clinical interest, neurophysiological mechanisms by which NGF
contribute to OA pain remain unclear. We investigated the impact of local elevation of knee joint NGF on
knee joint, vs remote (hindpaw), evoked responses of spinal neurones in a rodent model of OA pain.
Design: In vivo spinal electrophysiology was carried out in anaesthetised rats with established pain
behaviour and joint pathology following intra-articular injection of monosodium iodoacetate (MIA), vs
injection of saline. Neuronal responses to knee joint extension and flexion, mechanical punctate stim-
ulation of the peripheral receptive fields over the knee and at a remote site (ipsilateral hind paw) were
studied before, and following, intra-articular injection of NGF (10 mg/50 ml) or saline.
Results: MIA-injected rats exhibited significant local (knee joint) and remote (lowered hindpaw with-
drawal thresholds) changes in pain behaviour, and joint pathology. Intra-articular injection of NGF
significantly (P < 0.05) increased knee extension-evoked firing of spinal neurones and the size of the
peripheral receptive fields of spinal neurones (100% increase) over the knee joint in MIA rats, compared
to controls. Intra-articular NGF injection did not significantly alter responses of spinal neurones following
noxious stimulation of the ipsilateral hind paw in MIA-injected rats.
Conclusion: The facilitatory effects of intra-articular injection of NGF on spinal neurones receiving input
from the knee joint provide a mechanistic basis for NGF mediated augmentation of OA knee pain,
however additional mechanisms may contribute to the spread of pain to remote sites.
© 2015 The Authors. Published by Elsevier Ltd and Osteoarthritis Research Society International. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Osteoarthritis (OA) is a leading cause of chronic pain and
disability in the developed world which is often refractory to
analgesia. The challenge of finding analgesic strategies which more
effectively target the associated pain requires a better under-
standing of the underlying pain mechanisms. Nerve growth factor
(NGF) is widely recognised as a mediator of chronic pain1,2. Evi-
dence for a contribution of NGF to OA pathophysiology includes
increased NGF in synovial fluid3, at the osteochondral junction4,
synovium5 and cartilage6 of people with OA.: V. Chapman, School of Life
entre, Nottingham, NG72UH,
uk (V. Chapman).
r Ltd and Osteoarthritis Research SBlockade of NGFwith tanzeumab, a humanised IgG2monoclonal
antibody against NGF, had robust analgesic effects in OA sufferers7
and more recently lower back pain8. However, safety issues with
this treatment strategy have impacted upon the progress of clinical
trials9, and importantly highlight the need for greater mechanistic
understanding of the contribution of NGF to OA pain. Models of OA
painmimic both aspects of the clinical pathologyand exhibit pain on
loading (weight bearing) and lowering of paw withdrawal thresh-
olds (PWT) at remote sites10. Preclinical studies reported a signifi-
cant correlation between NGFb levels and pain behaviour in the
murine destabilisation of the medial meniscus model of OA pain, in
which NGF blockade inhibited OA pain responses11.
OA is not only associated with pain from the site of injury, but
also lowered pain pressure thresholds from remote sites12,13 and
the presence of central sensitization14. We have shown that one of
the functional consequences of a local elevation in levels of NGFociety International. This is an open access article under the CC BY-NC-ND license
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bearing distribution (asymmetry), without any further change in
pain behaviour from remote sites (ipsilateral hindpaw) in the
monosodium iodoacetate (MIA) model of OA pain15, implying pain
phenotype specific roles of NGF. This pre-clinical observation is
consistent with the demonstration that the anti-NGF treatment
fasinumab significantly reduces knee pain on walking in OA pa-
tients16. In the context of ongoing clinical evaluation of the anal-
gesic potential of anti-NGF treatment strategies, it is of clinical
interest to determine the mechanisms that underlie the impact of
elevated knee joint levels of NGF on pain arising from both the knee
joint, and potentially remote sites. To address this important
question we have used established neurophysiological approaches
to determine the influence of local elevation of knee joint NGF on
the responses of spinal neurones to noxious stimulation of the
knee-joint, vs the hindpaw, in a rodent model of OA pain. The
findings of these preclinical studies provide new mechanistic evi-
dence for restricted contributions of knee joint NGF to specific OA
pain mechanisms.
Materials and methods
Rats (n ¼ 73) were purchased from Charles River U.K. All studies
were carried out in accordance with UK Home Office Animals
(Scientific Procedures) Act (1986) and follow the guidelines of the
International Association for the Study of Pain.
OA induction
Male Sprague Dawley rats (160e190 g) were briefly anes-
thetised with isoflurane (1.5e2% in 50% N2O50% O2). Joint damage
was induced by a single intra-articular injection of (MIA; 1 mg/
50 ml; Sigma U.K.; n ¼ 24 rats) in saline through the infra-patellar
ligament of the left knee10. Control rats received a single injection
of saline (50 ml) into the left knee in an identical manner (n ¼ 24
rats). All surgical procedures where performed under sterile con-
ditions in an animal procedure room away from animal holding
areas. The experimental unit was a single animal.
Behavioural testing
After intra-articular injection, rats were maintained under the
same conditions as during the preoperative period. The posture and
behaviour of the rats were carefully monitored following recovery
from the anaesthesia and throughout the study. Weight gain,
changes inhindpawweight-distributionandmechanicalwithdrawal
thresholds were recorded immediately prior to intra-articular in-
jection (day 0, baseline) and at regular intervals until day 21 post
injection. The tester was blinded to the injury at the time of testing.
Behavioural tests were always performed between 8am and noon.
Naïve or saline-injected rats distribute their weight evenly be-
tween both paws. Following joint injury, changes in weight distri-
bution are used an indicator of joint discomfort and associated pain
in the injured knee17. Weight-distribution through the left (ipsi-
lateral) and right (contralateral) knee were assessed using an
incapacitance tester (Linton Instrumentation, U.K.) as previously
described18. Mechanical hindpaw withdrawal thresholds were
assessed using calibrated von Frey monofilaments (Semmes-
Weinstein monofilaments of bending forces 1, 1.4, 2, 4, 6, 8, 10 and
15 g) applied to the plantar surface of the hind paw in ascending
order of bending force. Each hair was applied three times for
approximately 2e3 s periods or until a withdrawal response was
evoked. After a response, the paw was retested with the mono-
filaments in descending order until no response occurred at which
point the monofilaments were again applied in ascending orderuntil the response could once again be evoked. The monofilament
that evoked this final reflex was noted as the PWT.
In vivo electrophysiology
Electrophysiological studies of MIA or saline-injected rats
(weight at time of study 310e425 g) and naïve control rats (n ¼ 25,
weight at time of study 300e405 g) were performed (between 21
and 24 days post-injection for MIA and saline-treated rats, at which
time behaviour was stable). Based on published methods10, rats
were anaesthetised with inhalation anaesthetic (3% induction, 2%
surgery, 1e1.5% maintenance in 60% N2O, 40%O2 (flow rates:
300 cm3 min1, 200 cm3 min1, respectively)) and a tracheal can-
nulawas inserted. A laminectomywas performed and segments L1-
L4 (knee recordings19,20; or L4-L5 (hind paw recordings10;)) of the
spinal cord were exposed depending on the stimulation protocol
(see below). The spinal cord was held rigid by clamps rostral and
caudal to the exposed section. Extracellular single-unit recordings
of deep (500e1000 mm, laminae VeVI) wide dynamic range (WDR)
dorsal horn neurones were made with glass-coated tungsten mi-
croelectrodes. Laminar VeVI WDR neurones have well charac-
terised responses to noxious stimuli and exhibit graded responses
to noxious stimuli21. Electrodes were lowered through the spinal
cord in 10 mm steps with a SCAT-01 microdrive (Digitimer, UK) and
the depth of recorded neurones from the spinal cord surface were
recorded and verified at the end of the experiment. Action poten-
tials were digitised and analysed using a CED micro1401 interface
and Spike 2 software (Cambridge Electronic Design, UK). Core body
temperature was maintained at 36.5e37.5C by means of a heating
blanket connected to a rectal temperature probe. For knee joint
stimulation protocols, the input from cutaneous afferent neurones
was minimised by the application of local anaesthetic cream
(EMLA: 2.5% lidocaine and 2.5% prilocaine) to the skin over the knee
joint for 20e30 min. Following removal of the cream, the skin over
the knee joint was excised. Note, it was not possible to remove the
skin from the hind paw (as was the case for the knee joint) and
therefore evoked responses may reflect a greater proportion of
cutaneous input from the hind paw.
Recording of responses to stimulation of the knee joint (knee evoked
responses)
Spinal neurones (lumbar segments L1eL4) which had receptive
fields predominantly over the knee joint and were responsive to
mechanical stimulation, flexion (bend) or extension of the knee
joint within a physiological range and did not respond to stimula-
tion of the ankle or hind paw were recorded. A von Frey mono-
filament (of bending force 26 g (noxious)) was applied to the
receptive field over the knee joint for a period of 10 s and the
evoked firing of the spinal neurone was recorded (quantified as
mean frequency of firing). To mimic the normal movement of the
knee joint, responses of spinal neurones to extension of the knee
joint and then flexion of the knee joint, within physiological limits,
were recorded. To avoid movement or electrical interference con-
founding the extension or flexion-evoked firing, the knee joint was
moved to the new position and then the firing evoked over a period
of 5 s was recorded. Once baseline responses had been recorded,
the effects of intra-articular NGF vs saline on extension and flexion-
evoked firing were determined. Receptive field size of spinal neu-
rones innervating the knee joint mapped with a noxious 26 g von
Frey monofilament using established methods22. In order to pre-
vent stimulus driven sensitization of the peripheral tissues, we did
not deliver trains of peripheral stimuli to the area over which the
receptive field was expanded for quantification purposes, but
merely noted threshold responses (present or absent) to stimuli
applied to different parts of the receptive field. Trials of evoked
Fig. 1. Intra-articular injection of MIA produces (A) weight bearing asymmetry and (B)
decreased hindpaw withdrawal thresholds on the ipsilateral hind paw of MIA rats
(n ¼ 24 rats), compared to saline-injected rats (n ¼ 24 rats). The effects of intra-
articular MIA on the knee joint pathology were quantified in a sub-set of rats used
in this study. There was a significant increase in the appearance of macroscopic lesions
(C) on the articular joint surface of MIA-injected rats, compared to saline-injected rats
(n ¼ 12 MIA rats; n ¼ 11 saline rats). Statistical analysis of weight bearing asymmetry
and PWTs was performed using a 2-way ANOVA with a Bonferroni post-hoc test.
Statistical test of knee joint pathology was performed using a Mann Whitney test.
*P < 0.05, **P < 0.01, ***P < 0.001 MIA injection vs saline injection.
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tervals. Only one neurone was recorded per rat.
Recording of responses of spinal neurons to stimulation of the hind
paw (hind paw evoked responses)
In order to investigate the contribution of spinal sensitisation in
the models of OA pain, spinal neuronal responses to stimulation of
an area remote to the knee joint (the ipsilateral hind paw) were
measured in a separate cohort of rats. Spinal neurones (lumbar
segments L4eL5) which had receptive fields over the toes and did
not respond to movement/stimulation of the ankle or knee were
recorded. Responses of spinal neurones to a mechanical punctate
stimulus (von Frey monofilament 26 g) applied to the peripheral
receptive field over the hind pawwere characterised and quantified
in a similar fashion as described above. Receptive field size of the
neurones over the hindpaw was mapped with a 26 g von Frey
monofilament. Trials of evoked responses and receptive field size
were recorded at 20 min intervals.
Intra-articular injection of NGF
Following stable control responses of spinal neurones to stim-
ulation of the knee or the hind paw, rats received a single intra-
articular injection through the infrapatellar ligament of either
NGF (10 mg/50 ml; Sigma UK), dose based on15 or saline (50 ml).
Responses of spinal neurones to the stimulation protocols
described above were quantified at 20 min intervals for 2 h post-
injection. Intra-articular injection of substances required the
movement of the joint, thus it was not possible to measure the
immediate effects of the injection on neuronal firing. At the end of
the experiment rats were killed by anaesthetic overdose and knee
joints were collected and a subgroup were processed.
Macroscopic grading of knee joint pathology
Macroscopic scoring of knee joints was based on23. Macroscopic
lesions were graded as follows: 0 ¼ normal appearance; 1 ¼ slight
yellowish discolouration of the chondral surface; 2¼ little cartilage
erosions in load-bearing areas; 3 ¼ large erosions extending down
to the subchondral bone; and 4 ¼ large erosions with large areas of
subchondral bone exposure. Each of the chondral compartments of
the knee (the medial and lateral femoral condyles, the medial and
lateral tibia plateaux, the patella, and the femoral groove) were
graded by an observer blinded to intervention and in vivo data. The
six compartment scores were combined (for a maximum possible
score of 24) and the mean value calculated for each group.
Data analysis and statistics
Statistical analysis of changes in weight bearing between the hin-
dlimbs andmechanicalwithdrawal thresholdswas performedusing a
2-way Analysis of variance (ANOVA) with a Bonferroni post-hoc test.
Neuronal responses to stimulation of the knee or hindpaw were nor-
malised as a % of the pre-drug baseline values for individual cells,
statistical analyses of neuronal responses to knee or hind paw stim-
ulation (area under curve) were performed using a ManneWhitney
testoraKruskalWallis testwithaDunn'sposthoc test, according to the
number of unmatched groups. In analyses that used the Krus-
kaleWallis andManneWhitney statistical tests, all observationswere
independent (data were unpaired) and non-Gaussian; in data ana-
lysed using repeated measures two-way ANOVA, data were matched
withinagroupandsphericitywasassumed.Peripheral receptivefields
tomechanical stimulation of the knee joint or hindpawweremapped
onto a template of the hind limb or hind paw, respectively. Receptive
field maps were scanned and converted to 300 dpi JPEG files and the
area of the receptive field was quantified using MacBiophotonicsImage J software. Baseline receptive field size was calculated as a % of
the mean of three receptive field sizes prior to injection of NGF or
saline. Statistical analyses of receptive field expansion (area under
curve) was performed a Mann Whitney test or a Kruskal Wallis test
with a Dunn's post hoc test, where appropriate. Statistical analysis of
knee joint pathology was performed using a MannWhitney test.
Results
Pain behaviour and joint pathology
Consistent with previous studies, intra-articular injection of
MIA (1 mg/50 ml) produced a decrease in weight bearing on the
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significantly different to saline-injected rats up to day 21 post-
injection [Fig. 1(A)]. In addition, MIA-injected rats exhibited a sig-
nificant decrease in mechanical hindpaw withdrawal thresholds,
compared to saline-injected rats [Fig. 1(B)]. At 21 days following
intra-articular injection of MIA there was an increase in the extent
of macroscopic lesions at the level of the articular surface of the
ipsilateral knee joint, compared to saline-injected rats [Fig. 1(C)].In vivo spinal electrophysiology
Following characterisation of the pain behaviour associated
with intra-articular injection of MIA, electrophysiological re-
cordings of spinal neurones were performed. The mean depths of
WDR spinal neurones recorded were similar between the experi-
mental groups (Table I) and corresponded to laminae V and VI of
the dorsal horn of the spinal cord. All spinal neurones recorded
were responsive to noxious (26 g) mechanical stimulation of the
peripheral receptive field, which was either over the ipsilateral
knee joint or hindpaw, and had a basal spontaneous firing rate of
less than 5 Hz.Does intra-articular injection of NGF alter knee joint evoked
responses of spinal neurones?
Flexion (bend) and extension of the knee joint within physio-
logical ranges increased the frequency of firing of spinal neurones
to a similar extent in MIA-injected and saline-injected rats (Table I).
Intra-articular injection of NGF in MIA-injected rats resulted in a
significant increase in the firing of spinal neurones following
extension of the knee, compared to saline-treated rats [Fig. 2(A),
(B), Supplementary Fig. 1]. By contrast, intra-articular injection of
NGF did not alter the firing of spinal neurones following extension
of the knee in saline-injected rats [Fig. 2(A), (B)]. Intra-articular
injection of NGF also resulted in a significant (100% increase)
expansion in the size of the receptive fields of the spinal neurones
innervating the knee joint in MIA-injected rats, compared to the
injection of saline in MIA-injected rats [Fig. 2(C)e(F)]. Intra-Table I
Summary of the treatment groups and the properties of the dorsal horn spinal neurones in
into the knee. Neurones had a basal spontaneous activity of less than 5 Hz. Neuronal respo
mean ± sem
Treatment group Mean depth of
neurone (mm)
B
st
Baseline neuronal responses: knee joint stimulation
Naïve rats
n ¼ 7 neurones in seven rats NGF 962 ± 74
n ¼ 6 neurones in six rats Saline 887 ± 51
MIA rats
n ¼ 6 neurones in six rats NGF 734 ± 69
n ¼ 6 neurones in six rats Saline 776 ± 74 1
Saline rats
n ¼ 6 neurones in six rats NGF 722 ± 87
n ¼ 7 neurones in seven rats Saline 742 ± 83
Treatment group Mean
Baseline neuronal responses: hind paw stimulation
Naïve rats
n ¼ 6 neurones in six rats NGF 842 ±
n ¼ 6 neurones in six rats Saline 796 ±
MIA rats
n ¼ 6 neurones in six rats NGF 780 ±
n ¼ 6 neurones in six rats Saline 778 ±
Saline rats
n ¼ 6 neurones in six rats NGF 735 ±
n ¼ 5 neurones in five rats Saline 680 ±articular injection of NGF did not alter the size of the receptive
fields of the spinal neurones innervating the knee joint in saline-
injected rats [Fig. 2(C)e(F)]. Intra-articular injection of NGF did
not alter knee flexion (bend) evoked firing [Fig. 2(G), (H)], nor
mechanical punctate evoked firing [Fig. 2(I), (J)], of spinal neurones
inMIA-injected, or saline-injected rats. Note the baseline responses
of spinal neurones in saline-injected rats were largely comparable
to those recorded in naïve rats; similarly the effects of intra-
articular injection of NGF in saline-treated rats were largely com-
parable to effects of intra-articular injection of NGF in naïve rats
(Supplementary Fig. 2(A)e(H)).Does intra-articular NGF alter hind paw evoked responses of spinal
neurones?
To investigate whether local knee joint changes in NGF can alter
the processing of sensory inputs from remote sites, the effects of an
intra-articular injection of NGF or saline on the responses of spinal
neurones with receptive fields over the ipsilateral hindpaw, but not
the ipsilateral knee joint, were recorded in MIA-treated rats.
Neither intra-articular injection of saline, or NGF altered noxious
(26 g) hindpaw evoked responses of spinal neurones [Fig. 3(A)e(B)]
or the size of the receptive fields of spinal neurones innervating the
hindpaw in MIA-injected or saline-injected rats [Fig. 3(C)e(D)], or
naïve rats (data not shown).Discussion
Recent work has reported an association between NGF-like
immunoreactivity in human synovium and the presence of symp-
tomatic OA5. Hereinwe demonstrate that elevation of local levels of
NGF within the knee joint significantly facilitates knee joint
extension-evoked responses of spinal neurones and increases the
receptive field size of spinal neurones innervating the knee joint in
the MIA model of OA pain, to a greater extent than in naïve or
control rats. The effects of NGF on spinal neuronal responses were
restricted to those receiving input from the knee joint since ipsi-
lateral hindpaw-evoked responses were not significantlythe different groups of rats at baseline before injection of NGF (10 mg/50 ml) or saline
nses between groups did not significantly differ from each other at baseline. Data are
aseline 26 g-evoked
imulation (Hz)
Baseline knee flexion
evoked firing (Hz)
Baseline knee extension
evoked firing (Hz)
9 ± 4 7 ± 2 17 ± 6
8 ± 4 4 ± 1 9 ± 2
8 ± 3 5 ± 1 9 ± 4
2 ± 4 6 ± 3 7 ± 3
9 ± 2 6 ± 2 9 ± 3
7 ± 1 8 ± 2 17 ± 6
depth of neurone (mm) Baseline 26 g-evoked stimulation (Hz)
121 37 ± 12
34 19 ± 4
63 22 ± 4
51 47 ± 7
47 32 ± 6
32 28 ± 7
Fig. 2. Effects of intra-articular injection of NGF or saline in MIA and saline-injected rats on spinal neuronal responses to (A,B) knee extension, (CeD)26 g receptive field size of
spinal neurones innervating the knee joint, in MIA-injected and saline-injected rats. (EeF) A representative image of mapping the peripheral receptive field over the knee joint
following stimulation with a 26 g von Frey hair (E) pre- and (F) 2 h post-NGF injection; the shaded area indicates areas over which stimulation was able to evoke single unit activity
of a dorsal horn neurone in the spinal cord. Panels show effects of intra-articular injection of NGF or saline in MIA and saline-injected rats on spinal neuronal responses to (GeH)
knee flexion (bend) and (IeJ) 26 g von Frey punctate stimulation over the knee joint in MIA-injected and saline-injected rats. Data are normalised to baseline values and expressed
as mean ± SEM. Statistical analyses comparing the area under curve were performed using a Kruskal Wallis test with a Dunn's post hoc test. *P < 0.05. MIA-NGF: n ¼ 6 neurones in
six rats; MIA-saline: n ¼ 6 neurones in six rats, Saline-NGF: n ¼ 6 neurones in six rats, Salineesaline: n ¼ 7 neurones in seven rats.
Fig. 3. Effects of intra-articular injection of NGF or saline in MIA or saline-injected rats on spinal neuronal responses to (AeB) 26 g von Frey stimulation and (CeD) 26 g receptive
field size of neurones innervating the hind paw. Data are normalised to baseline values and expressed as mean ± SEM. Statistical analyses comparing the area under curve were
performed using a Kruskal Wallis test. MIA-NGF: n ¼ 6 neurones in six rats; MIA-saline: n ¼ 6 neurones in six rats; saline-NGF: n ¼ 6 neurones in six rats; salineesaline: n ¼ 5
neurones in five rats.
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pain. These neurophysiological studies provide new insight into the
mechanisms which underpin the contribution of NGF to OA pain,
which are relevant the analgesic effects of anti-NGF treatment
strategies for OA pain.
Although the MIA model does not mimic the aetiology of clinical
OA, the histopathological features of the joint damage and the phe-
notypes of pain exhibited (pain on loading and spread of pain to sites
distant from the joint) provide a clinically relevant model for the
investigation ofmechanisms drivingestablishedOApain24. Following
intra-articular injection of MIA, rats displayed a characteristic
decrease in weight bearing and ipsilateral mechanical hind PWTs
compared to saline-injected rats, which mimics aspects of the spatial
summationand spreadof painevident inOApatients25. Previouslywe
have demonstrated significant increases in numbers of activated
microglia in the spinal cord at day 21 in the MIA model26, indicating
thepresence of features of central sensitization at the time-point used
for this neurophysiological investigation. It was noteworthy that the
magnitude of mechanically-evoked punctate responses was consis-
tently higher following stimulation of the hindpaw, compared to
stimulation of the knee joint, which may reflect the relatively low
innervation of the knee joint by primary afferent fibres27 and an
additional contribution of cutaneous input from the hind paw to the
spinal cord. Macroscopic evaluation of knee joints in a subset of the
MIA-treated rats confirmed thepresenceof histopathological features
consistent with clinical OA, compared to saline-injected rats.
Exogenous elevation of NGF within the knee joint, at a dose
previously shown to produce pain behaviour15, produced a signif-
icant increase in knee extension-evoked firing of spinal neurones
and a robust significant increase in the size of the peripheral
receptive fields of the spinal neurones innervating the knee joint.
These effects, which were specific to the MIA model and significantcompared to naïve and saline-injected controls, provide a neuro-
physiological basis for the robust effects of knee joint NGF on
weight bearing measures of pain behaviour in this model, which
may be underpinned by the increased mRNA expression of the high
affinity receptor for NGF TrkA at the level of the DRG in this
model15. Since the present study was unable to distinguish be-
tween spinal neurones receiving inputs from intracapsule vs
extracapsule afferent fibres, differential effects of NGF on these
types of sensory inputs could not be identified. The ability of local
elevation of knee joint NGF to facilitate knee extension-evoked
firing of spinal neurones may represent changes in sensory inputs
from multiple structures within the knee joint, including muscle.
Enhanced spinal withdrawal reflexes at the level of the biceps
femoris muscle (involved in flexion of the knee) have been
demonstrated in the MIA model28 and significant enhancement of
pain responses following intramuscular hypertonic saline in OA
patients29 is indicative of an enhanced sensitivity of the central
processing of muscle inputs following joint damage.
Importantly, intra-articular injection of NGF did not alter the
responses of spinal neurones to hind paw stimulation in MIA-
treated rats, either in terms of magnitude of evoked firing or the
size of the receptive field of neurones innervating the hind paw.
Our data suggest that despite MIA-induced knee joint damage
driving changes in the spinal processing of sensory inputs from the
hindpaw as evidenced by the lowering of hindpaw withdrawal
thresholds, elevation of local knee joint levels of NGF is unlikely to
contribute to this effect. Indeed, the contribution of knee joint NGF
to OA pain may be restricted to peripherally driven events, at least
at the time-points investigated in the present study, and any
spinally-mediated effects may be restricted to the lumbar segments
receiving input predominantly from the joint and not lower seg-
ments receiving hind paw input.
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elevated levels of NGF and OA (see Introduction) and preclinical
studies have demonstrated that repeated exposure to NGF drives a
long lasting hypersensitivity, including an expansion of receptive
fields of spinal neurones in response to stimulation of deep tis-
sues30. Although NGF increased spinal neuronal responses in both
arthritic and non-arthritic rats, the magnitude of the effects was
two fold greater in the MIA-injected rats. Our neurophysiological
data provide evidence that the up-regulation of the NGF/TrkA
system in a model of OA15 is associated with a spinal sensitization
which facilitates extension-evoked firing of spinal neurones, as
well as expanding the area over which sensory inputs from the
knee joint can activate individual spinal neurones. Given the
complexity of the structures contributing to OA pathology and pain,
several mechanisms are likely to contribute to NGF-mediated
changes in spinal neuronal responses. These may include periph-
eral sensitisation, as well as changes in spinal excitability (central
sensitisation), as evidenced by the presence of receptive field
expansion. The ability of NGF to prime the sensory nervous system
is unlikely to occur in isolation as NGF can induce peripheral
sensitisation through the release of neuropeptides such as CGRP31
and facilitation of TRPV1 responses32, both of which have estab-
lished associations with OA pain27,33e35. Indeed, in addition to the
effects on thermal hypersensitivity, NGF driven mechanical
hyperalgesia is TRPV1 dependant36. Interactions between NGF and
other pro-inflammatory substances (e.g., cytokines37), endova-
nilloids35, infiltrating macrophages and altered channel and re-
ceptor expression on sensory nerves may all contribute to these
sensitization mechanisms. The observation that the effects of knee
joint NGF were limited to spinal neurones receiving input from the
knee joint, and did not extend to neurones innervating the hind-
paw, suggests that peripheral NGF mechanisms may augment OA
knee pain, while additional mechanisms may contribute to the
spread of pain to remote sites. This novel insight into the neuro-
physiological contribution of NGF-to OA pain mechanisms may
have important implications for treatment strategies which target
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